Stock Track | Nuvation Bio (NUVB) Soars 5.13% on Positive Analyst Ratings and Price Target Hikes

Stock Track

Aug 08, 2025

Nuvation Bio, Inc. (NUVB) shares surged 5.13% in pre-market trading on Friday, following a series of positive analyst reports and price target increases. The biotechnology company's stock received a boost as multiple research firms expressed confidence in its future prospects.

RBC Capital Markets raised its price target on Nuvation Bio to $7 from $6, while maintaining an Outperform rating with a Speculative Risk assessment. This upward revision suggests growing optimism about the company's potential. Additionally, H.C. Wainwright reiterated its Buy rating on NUVB, setting an even more ambitious price target of $10 per share.

The positive sentiment is further reinforced by the overall analyst consensus. According to FactSet, Nuvation Bio currently has an average rating of Buy, with a mean price target of $8.14. This bullish outlook from Wall Street analysts appears to be driving investor enthusiasm, contributing to the stock's significant pre-market rally. As Nuvation Bio continues to develop its pipeline of oncology therapeutics, investors will be closely watching for further updates on the company's progress and any additional analyst recommendations.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1139389565"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1139389565\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1139389565?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-08 21:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1139389565","market":"sg","top_or_hot":-1,"title":"Stock Track | Nuvation Bio (NUVB) Soars 5.13% on Positive Analyst Ratings and Price Target Hikes","media":"Stock Track","content":"<p>Nuvation Bio, Inc. (NUVB) shares surged 5.13% in pre-market trading on Friday, following a series of positive analyst reports and price target increases. The biotechnology company's stock received a boost as multiple research firms expressed confidence in its future prospects.</p>\n\n<p>RBC Capital Markets raised its price target on Nuvation Bio to $7 from $6, while maintaining an Outperform rating with a Speculative Risk assessment. This upward revision suggests growing optimism about the company's potential. Additionally, H.C. Wainwright reiterated its Buy rating on NUVB, setting an even more ambitious price target of $10 per share.</p>\n\n<p>The positive sentiment is further reinforced by the overall analyst consensus. According to FactSet, Nuvation Bio currently has an average rating of Buy, with a mean price target of $8.14. This bullish outlook from Wall Street analysts appears to be driving investor enthusiasm, contributing to the stock's significant pre-market rally. As Nuvation Bio continues to develop its pipeline of oncology therapeutics, investors will be closely watching for further updates on the company's progress and any additional analyst recommendations.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Nuvation Bio (NUVB) Soars 5.13% on Positive Analyst Ratings and Price Target Hikes</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Nuvation Bio (NUVB) Soars 5.13% on Positive Analyst Ratings and Price Target Hikes\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-08-08 21:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Nuvation Bio, Inc. (NUVB) shares surged 5.13% in pre-market trading on Friday, following a series of positive analyst reports and price target increases. The biotechnology company's stock received a boost as multiple research firms expressed confidence in its future prospects.</p>\n\n<p>RBC Capital Markets raised its price target on Nuvation Bio to $7 from $6, while maintaining an Outperform rating with a Speculative Risk assessment. This upward revision suggests growing optimism about the company's potential. Additionally, H.C. Wainwright reiterated its Buy rating on NUVB, setting an even more ambitious price target of $10 per share.</p>\n\n<p>The positive sentiment is further reinforced by the overall analyst consensus. According to FactSet, Nuvation Bio currently has an average rating of Buy, with a mean price target of $8.14. This bullish outlook from Wall Street analysts appears to be driving investor enthusiasm, contributing to the stock's significant pre-market rally. As Nuvation Bio continues to develop its pipeline of oncology therapeutics, investors will be closely watching for further updates on the company's progress and any additional analyst recommendations.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NUVB","symbol_name":"Nuvation Bio, Inc.","start_time":0,"source_url":"","article_id":"1139389565","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1139389565","pubTimestamp":1754660131,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Nuvation Bio, Inc. (NUVB) shares surged 5.13% in pre-market trading on Friday, following a series of positive analyst reports and price target increases. The biotechnology company's stock received a...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"NUVB":"Nuvation Bio, Inc."},"translate_title":"股票追踪|Nuvation Bio(NUVB)因分析师积极评级和目标价上调而飙升5.13%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NUVB":1},"content_text":"Nuvation Bio, Inc. (NUVB) shares surged 5.13% in pre-market trading on Friday, following a series of positive analyst reports and price target increases. The biotechnology company's stock received a boost as multiple research firms expressed confidence in its future prospects.\nRBC Capital Markets raised its price target on Nuvation Bio to $7 from $6, while maintaining an Outperform rating with a Speculative Risk assessment. This upward revision suggests growing optimism about the company's potential. Additionally, H.C. Wainwright reiterated its Buy rating on NUVB, setting an even more ambitious price target of $10 per share.\nThe positive sentiment is further reinforced by the overall analyst consensus. According to FactSet, Nuvation Bio currently has an average rating of Buy, with a mean price target of $8.14. This bullish outlook from Wall Street analysts appears to be driving investor enthusiasm, contributing to the stock's significant pre-market rally. As Nuvation Bio continues to develop its pipeline of oncology therapeutics, investors will be closely watching for further updates on the company's progress and any additional analyst recommendations.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}